pHLIP, Inc.

“pHLIP Inc. acts as a molecular nanosyringe, inserting itself into the cell membrane and injecting compounds into cells,” said co-founder, president, and URI Professor Yana Reshetnyak.

What: Healthcare startup

Innovation: Nanotechnology platform for highly sensitive cancer imaging and treatment.

Who: URI professors Oleg Andreev and Yana Reshetnyak, and Yale University professor Donald Engelman

Market: Cancer treatment, including breast, prostate, bladder, melanoma, lymphoma, pancreatic, lung, ovarian, and brain.

Idea: Enable targeted delivery of therapeutic, diagnostic, prophylactic, and research agents to cells in diseased acidic tissues, including cancers, ischemic myocardium, inflammatory arthritis, and stroke.

Notes: Licensed technology to URI startup Optera Diagnostics.

pHLIP, Inc. website